IRIS
DE SERVI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.010
EU - Europa 1.343
AS - Asia 759
AF - Africa 6
SA - Sud America 1
Totale 4.119
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.003
CN - Cina 677
IE - Irlanda 371
UA - Ucraina 224
SE - Svezia 223
FI - Finlandia 179
DE - Germania 127
GB - Regno Unito 107
SG - Singapore 62
IT - Italia 59
FR - Francia 29
BE - Belgio 10
CA - Canada 7
NL - Olanda 7
IN - India 6
KR - Corea 6
MU - Mauritius 5
CZ - Repubblica Ceca 3
IR - Iran 3
LT - Lituania 3
JP - Giappone 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
HK - Hong Kong 1
LV - Lettonia 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 4.119
Salva come PNG Salva come JPEG
Città #
Chandler 441
Dublin 371
Jacksonville 248
Ashburn 194
Nanjing 175
Boardman 117
Wilmington 107
Ann Arbor 89
Beijing 84
Princeton 75
Helsinki 74
Nanchang 72
Lawrence 70
Medford 65
Shenyang 63
Hebei 54
New York 54
Changsha 45
Jiaxing 44
Singapore 41
Houston 36
Hangzhou 35
Tianjin 34
Woodbridge 34
Dearborn 31
Milan 23
Los Angeles 22
Shanghai 21
Verona 18
Fairfield 17
Norwalk 13
Pavia 13
Brussels 10
Des Moines 8
Jinan 7
Toronto 6
Falkenstein 5
Seattle 5
Taizhou 5
Berlin 4
Borås 4
Guangzhou 4
Hefei 4
Ningbo 4
Redwood City 4
Zhengzhou 4
Brno 3
Lanzhou 3
Munich 3
Tappahannock 3
Eden Prairie 2
Fuzhou 2
London 2
Monmouth Junction 2
Piscataway 2
Santa Clara 2
Tabriz 2
Tokyo 2
Alexandria 1
Andover 1
Arcore 1
Arnesano 1
Auburn Hills 1
Benxi 1
Bologna 1
Centurion 1
Chengdu 1
Dallas 1
Delhi 1
Didcot 1
Fayetteville 1
Frankfurt am Main 1
Hong Kong 1
Islamabad 1
Kashan 1
Leawood 1
Linyi 1
Orange 1
Ottawa 1
Pune 1
Riga 1
Rockville 1
San Francisco 1
Shaoxing 1
Turin 1
Vadodara 1
Xian 1
Totale 2.911
Salva come PNG Salva come JPEG
Nome #
CoreValve implantation for severe aortic regurgitation: a multicentre registry. 95
Causes and clinical implications of premature discontinuation of dual antiplatelet therapy. 90
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve revalving system 87
Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review. 87
Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System. 85
Anemia in octogenarians with non-ST elevation acute coronary syndrome: aging or disease? 84
Does the target vessel impact on results of percutaneous coronary intervention for bifurcation lesions? Insights from the I-BIGIS registry. 83
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus. 80
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 79
Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with st-elevation myocardial infarction and multivessel disease: a meta-analysis. 79
Causes of death in patients ≥75 years of age with non-ST-segment elevation acute coronary syndrome. 77
Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. 76
Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention 75
One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia. 75
Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor. 74
Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. 72
Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology. 72
Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials. 72
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction. 72
Early Aggressive Versus Initially Conservative Treatment in Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndrome A Randomized Controlled Trial 72
Quality and appropriateness of coronary angioplasty in Lombardy: analysis of data from the registry of the Italian Society of Invasive Cardiology (SICI-GISE)]. 71
Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. 71
Trilogy: In search of the lost ring. 70
Impact of Gene Polymorphisms, Platelet Reactivity, and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 70
Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial. 70
Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter? 69
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. 69
Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes. 69
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. 67
Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure 67
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 66
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry. 64
Absence of correlation between coronary thrombosis and postatherectomy restenosis 64
How to reduce mortality in ST-elevation myocardial infarction patients treated with primary percutaneous coronary interventions: cut the bleeding. 62
LombardIMA: a regional registry for coronary angioplasty in ST-elevation myocardial infarction. 62
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 62
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. 62
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. 61
Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions. 61
Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. 61
The bivalirudin paradox: high evidence, low use. 60
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes - results from the BASKET PROVE trial. 58
To kiss or not to kiss? Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions. 57
Renal function estimation and one-year mortality in elderly patients with non-ST-segment elevation acute coronary syndromes. 55
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 55
Interplay between Mitral Regurgitation and Transcatheter Aortic Valve Replacement with the CoreValve Revalving System: A Multicenter Registry. 55
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 52
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 50
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 49
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 49
Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease 47
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 47
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 46
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 45
Histopathologic features in atherectomy samples obtained from patient with unstable angina, stable angina and restenosis. Directional Atherectomy Lombardi Group 42
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 42
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 42
Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. 40
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. 39
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 38
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 37
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. 35
How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial? 35
Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies. 35
Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry. 34
Leptin affects the inflammatory response after STEMI 34
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 34
Association of statin pretreatment with presentation characteristics, infarct size and outcome in older patients with acute coronary syndrome: the Elderly ACS-2 trial 30
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 25
Percutaneous coronary interventions for stable ischemic heart disease in Italy 16
Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties 13
Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT registry 12
Derivation and validation of the incomplete ST-segment resolution score and its usefulness for treatment with glycoprotein IIb-IIIa inhibitors 4
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 4
Neutrophil count as a risk factor for cardiovascular diseases: How can we manage it? 3
Totale 4.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020212 0 0 0 0 0 0 10 60 2 93 33 14
2020/2021550 41 38 35 40 4 77 5 85 40 75 75 35
2021/2022302 5 3 4 2 5 1 5 24 20 9 44 180
2022/20231.197 178 92 10 93 143 104 0 74 441 6 28 28
2023/2024338 34 79 9 15 28 111 2 22 2 20 9 7
2024/2025212 24 83 24 18 22 41 0 0 0 0 0 0
Totale 4.223